tiprankstipranks
IGM Biosciences Inc (IGMS)
NASDAQ:IGMS
US Market

IGM Biosciences (IGMS) Income Statement

Compare
336 Followers

IGM Biosciences Income Statement

Last quarter (Q4 2024), IGM Biosciences's total revenue was $412.00K, a decrease of -36.71% from the same quarter last year. In Q4, IGM Biosciences's net income was $-36.65M. See IGM Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 2.68M$ 2.13M$ 1.07M$ 0.00$ 0.00
Gross Profit
$ 2.68M$ -6.15M$ -9.53M$ -7.72M$ -3.58M
Operating Expenses
$ 211.26M$ 265.59M$ 229.03M$ 165.32M$ 83.28M
Depreciation and Amortization
$ 0.00$ 8.28M$ 10.60M$ 7.72M$ 3.58M
EBITDA
$ -208.58M$ -253.36M$ -221.88M$ -157.44M$ -77.78M
Operating Income
$ -208.58M$ -263.46M$ -227.96M$ -165.32M$ -83.28M
Other Income/Expenses
$ 12.79M$ 17.72M$ 6.85M$ 159.00K$ 1.93M
Pretax Income
$ -195.79M$ -245.74M$ -221.10M$ -165.16M$ -81.36M
Net Income
$ -195.79M$ -246.42M$ -214.25M$ -160.68M$ -80.33M
Per Share Metrics
Basic EPS
$ -3.24$ -4.71$ -5.16$ -4.80$ -2.61
Diluted EPS
$ -3.24$ -4.71$ -5.16$ -4.80$ -2.61
Weighted Average Shares Outstanding
60.51M 52.31M 41.54M 33.48M 30.75M
Weighted Average Shares Outstanding (Diluted)
60.51M 52.31M 41.54M 33.48M 30.75M
Currency in USD

IGM Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis